Carregant...

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Intranasal delivery provides a practical, non-invasive method of bypassing the blood-brain barrier (BBB) to deliver therapeutic agents to the brain and spinal cord. This technology allows drugs that do not cross the BBB to be delivered to the central nervous system within minutes. It also directly d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hanson, Leah R, Frey, William H
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2604883/
https://ncbi.nlm.nih.gov/pubmed/19091002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-9-S3-S5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!